Advanced search
Publication Cover
Cancer Management and Research Volume 10, 2018 - Issue
Submit an article Journal homepage
68
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Blockage of store-operated Ca2+ entry antagonizes Epstein–Barr virus-promoted angiogenesis by inhibiting Ca2+ signaling-regulated VEGF production in nasopharyngeal carcinoma

Jiaxiang Ye1 Department of Medical Oncology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China
,
Junqi Huang2 Department of Pathology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China
,
Qian He3 Institute for the Advancement of Higher Education, Hokkaido University, Sapporo, Japan
,
Weilin Zhao4 Department of Otolaryngology-Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China
,
Xiaoying Zhou5 Life Science Institute, Guangxi Medical University, Nanning 530021, People’s Republic of China
,
Zhe Zhang4 Department of Otolaryngology-Head and Neck Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China
,
Yongqiang Li1 Department of Medical Oncology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of China
,
Jiazhang Wei6 Department of Otolaryngology and Head and Neck Oncology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021, People’s Republic of ChinaCorrespondence[email protected]
&
Jinyan Zhang1 Department of Medical Oncology, Affiliated Cancer Hospital of Guangxi Medical University, Nanning 530021, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 1115-1124 | Published online: 10 May 2018

References

  • VokesEELiebowitzDNWeichselbaumRRNasopharyngeal carcinomaLancet199735090841087109110213566
  • TaoQChanATNasopharyngeal carcinoma: molecular pathogenesis and therapeutic developmentsExpert Rev Mol Med2007912124
  • YoungLSRickinsonABEpstein-Barr virus: 40 years onNat Rev Cancer200441075776815510157
  • Raab-TraubNEpstein-Barr virus in the pathogenesis of NPCSemin Cancer Biol200212643144112450729
  • DawsonCWPortRJYoungLSThe role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)Semin Cancer Biol201222214415322249143
  • YoshizakiTKondoSWakisakaNPathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinomaCancer Lett201333711723689138
  • ZhangJWeiJKanadaMInhibition of store-operated Ca2+ entry suppresses EGF-induced migration and eliminates extravasation from vasculature in nasopharyngeal carcinoma cellCancer Lett2013336239039723623984
  • WeiJZhangJSiYBlockage of LMP1-modulated store-operated Ca(2+) entry reduces metastatic potential in nasopharyngeal carcinoma cellCancer Lett2015360223424425697483
  • ZhangJWeiJHeQSKF95365 induces apoptosis and cell-cycle arrest by disturbing oncogenic Ca(2+) signaling in nasopharyngeal carcinoma cellsOnco Targets Ther201583123313326604781
  • LoAKLoKWTsaoSWEpstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cellsNeoplasia20068317318016611410
  • MaruoSYangLTakadaKRoles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cellsJ Gen Virol200182pt 102373238311562531
  • WeiJTakeuchiKWatanabeHLinoleic acid attenuates endothelium-derived relaxing factor production by suppressing cAMP-hydrolyzing phosphodiesterase activityCirc J201377112823283023883876
  • LawEWCheungAKKashubaVIAnti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinomaOncogene201231672873821743496
  • National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory AnimalsGuide for the Care and Use of Laboratory Animals8th edWashington, DCNational Academies Press2011
  • ChenYFChiuWTChenYTCalcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesisProc Natl Acad Sci U S A201110837152251523021876174
  • Muralidharan-ChariVClancyJWSedgwickAD’Souza-SchoreyCMicrovesicles: mediators of extracellular communication during cancer progressionJ Cell Sci2010123pt 101603161120445011
  • MaruyamaTKanajiTNakadeSKannoTMikoshibaK2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ releaseJ Biochem199712234985059348075
  • BootmanMDCollinsTJMackenzieLRoderickHLBerridgeMJPeppiattCM2-Aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ releaseFASEB J200216101145115012153982
  • SoulsbyMDWojcikiewiczRJ2-Aminoethoxydiphenyl borate inhibits inositol 1,4,5-trisphosphate receptor function, ubiquitination and downregulation, but acts with variable characteristics in different cell typesCell Calcium200232417518112379177
  • MillerWEEarpHSRaab-TraubNThe Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptorJ Virol1995697439043987769701
  • ThornburgNJRaab-TraubNInduction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexesJ Virol20078123129541296117881446
  • KungCPRaab-TraubNEpstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3J Virol200882115486549318367518
  • KungCPMeckesDGJrRaab-TraubNEpstein-Barr virus LMP1 activates EGFR, STAT3, and ERK through effects on PKCdeltaJ Virol20118594399440821307189
  • ElserCSiuLLWinquistEPhase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinomaJ Clin Oncol200725243766377317704426
  • LeeNYZhangQPfisterDGPhase II study of the addition of bevacizumab to standard chemoradiation for loco-regionally advanced nasopharyngeal carcinoma: Radiation Therapy Oncology Group (RTOG) trial 0615Lancet Oncol201213217218022178121
  • ClaphamDECalcium signalingCell200713161047105818083096
  • HanahanDWeinbergRAHallmarks of cancer: the next generationCell2011144564667421376230

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.